Medicine and Dentistry
Breast Cancer
100%
Lumpectomy
78%
Intraoperative Radiation Therapy
58%
Neoplasm
56%
Surgery
44%
Breast Cancer-Related Lymphedema
41%
Intraductal Carcinoma
35%
Radiation Therapy
32%
Biopsy
31%
Mastectomy
31%
Quadrantectomy
30%
Malignant Neoplasm
28%
Wilms' Tumor
27%
Disease
25%
Surgeon
25%
Minimal Residual Disease
20%
Recurrent Disease
18%
Multivariate Analysis
17%
Lymph Node
17%
Cancer Diagnosis
17%
Reoperation
16%
Systematic Review
16%
Vasopressin
13%
Overall Survival
13%
Artery
13%
Ganglioneuroblastoma
13%
Acinar Cell
13%
Retrospective Study
13%
Underserved Population
13%
Cancer Therapy
13%
Clear Cell Renal Cell Carcinoma
13%
Salivary Gland
13%
Pediatrics
13%
Mucoepidermoid Carcinoma
13%
Cancer Risk
13%
Atypical Hyperplasia
13%
Cystadenoma
13%
Collaborative Learning
13%
in Vivo Dosimetry
13%
Hemorrhagic Cystitis
13%
Shared Decision Making
13%
Anaplastic Carcinoma
13%
Lobular Carcinoma in Situ
13%
Patient with Neuroblastoma
13%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
13%
Coronavirinae
13%
Pandemic
13%
Recurrence Risk
12%
Odds Ratio
11%
Celiac Artery
11%
Keyphrases
Lumpectomy
29%
Breast Cancer-related Lymphedema
27%
Breast Cancer Patients
19%
TARGIT
15%
Postoperative Morbidity
13%
Positive Margins
13%
Collaboration Protocol
13%
Mucoepidermoid
13%
Visceral Artery
13%
Nipple
13%
Local Control
13%
Breast Surgeon
13%
Chest Wall Involvement
13%
Oncoplastic Breast Surgery
13%
Bridge Measurements
13%
High-risk Neuroblastoma
13%
Reoperation
13%
Ethnically Diverse Populations
13%
Breast Cancer Prevention
13%
Skin Bridge
13%
Intraoperative Radiation Therapy
13%
Axillary Reverse Mapping
13%
Re-resection
13%
Underserved
13%
Breast
13%
Targeted Intraoperative Radiotherapy
13%
Synchronous Bilateral Breast Cancer
13%
Re-excision
13%
Breast Cancer Diagnosis
13%
American Society
13%
Clinical Utility
13%
Cavity Margin
13%
Postoperative Mortality
13%
HER2-positive Breast Cancer
13%
Neoadjuvant
13%
T-DM1
13%
Bridging Strategy
13%
Coronavirus disease-19 Pandemic
13%
Treatment Options
13%
Re-excision Rate
11%
Bilateral Breast Cancer
11%
Ethnic Minorities
8%
Reoperation Rate
8%
Radiation Therapy
7%
Laparoscopic Biopsy
6%
Atypical Breast Lesions
6%
Intellectual Disability
5%
Local Recurrence Rate
5%
MYCN Amplification
5%
Locally Recurrent
5%